Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$5,806,441
-$2,873,428 QoQ
Shares Held
4,841
-48.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#1,594
of 4,605 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ellsworth Advisors, LLC holds $34,290,994 across 6 Drug Manufacturers - General names. LLY ranks #4 (16.9% of the industry book) .
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,806,441 | 4,841 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $8,679,869 | 9,437 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $4,816,716 | 4,482 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $3,281,663 | 4,301 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,012,746 | 2,582 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,926,022 | 2,332 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $1,699,944 | 2,202 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $350,832 | 396 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $351,287 | 388 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $309,628 | 398 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $229,087 | 393 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $212,166 | 395 | Shares | Sole | 2023-10-20 | |
| No filing history on record for this holder in this stock. | ||||||